Results 41 to 50 of about 15,361 (245)

Sudomotor Testing of Diabetes Polyneuropathy [PDF]

Frontiers in Neurology, 2018
Objective: The performance of the Sudoscan technology for diagnosing diabetic polyneuropathy (DPN) was evaluated against the quantitative sudomotor axon reflex test (QSART). Furthermore, the association of Sudoscan with two clinical neuropathy scoring systems was evaluated. Methods: Forty-seven patients with type 2 diabetes (20 without DPN, 27 with DPN)
Sarah-Maria Krieger, Manja Reimann, Rocco Haase, Elena Henkel, Markolf Hanefeld, Tjalf Ziemssen   +5 more
openaire   +3 more sources

Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials

Pharmacological Research, 2022
Neuropathic pain is the most prevalent form of chronic pain caused by a disease of the nervous system, such as diabetic polyneuropathy. ɑ-Lipoic acid (ALA) is an antioxidant that has been widely studied for the treatment of pain symptoms in diverse ...
Gabriela Cassanego, Patrícia Rodrigues, Liliane De Freitas Bauermann, Gabriela Trevisan   +3 more
doaj   +1 more source

Diabetic Distal Symmetric Polyneuropathy: A Case Study [PDF]

, 2009
The most common form of diabetic neuropathy is diabetic distal symmetric polyneuropathy. It most frequently presents with distal sensory loss. Treatment of diabetic neuropathy is unsatisfactory in modern treatment.
Pratima Devi, Biswas, Sabyasachi, Sabyasachi Biswas, Devi, Pratima   +3 more
core   +2 more sources

Main metabolic and toxic polyneuropathies in clinical practice

Медицинский совет, 2021
Polyneuropathies are diseases of the peripheral nervous system with lesions of motor, sensory or autonomic fibers which are encountered by attending physicians of almost all specialties in outpatient and clinical settings.
N. V. Pizova
doaj   +1 more source

Effectiveness of thioctic acid drugs (Espa-lipon) in the treatment of diabetic polyneuropathy

Медицинский совет, 2015
This article tells about the treatment of diabetic polyneuropathy - the most common neurological complications of diabetes mellitus. The pathogenesis, diagnosis and current evidence-based treatments are described. Thioctic acid drugs for the treatment of
M. V. Nesterova, V. V. Galkin
doaj   +1 more source

Matrix metalloproteinase-2 (MMP-2 ) and-9 (MMP-9) gene variants and microvascular complications in type 2 diabetes patients

Balkan Journal of Medical Genetics, 2023
Vascular complications are the leading cause of increased morbidity and mortality of diabetic patients. It has been postulated that matrix metalloproteinases MMP-2 and MMP-9, zinc-dependent endopeptidases through remodeling of the extracellular matrix ...
Andjelic Jelic M, Radojkovic D, Nikolic A, Rakicevic Lj, Babic T, Jelic D, Lalic NM   +6 more
doaj   +1 more source

Quantitative study and related factors analysis of sciatic neuropathy in type 2 diabetes mellitus patients by elastic imaging virtual tissue imaging quantification technique

Hereditas
Background The incidence of diabetic peripheral neuropathy (DPN) is increasing every year for type 2 diabetes mellitus (T2DM) patients, and diabetic polyneuropathy is a common type.
Ruixing Liu, Beibei Yu, Gaopan Cao, Lina Ye, Dan Zhang   +4 more
doaj   +1 more source

Sustainable Effects of Human Dental Pulp Stem Cell Transplantation on Diabetic Polyneuropathy in Streptozotocine-Induced Type 1 Diabetes Model Mice

Cells, 2021
Dental pulp stem cells (DPSCs) are suitable for use in regenerative medicine. Cryopreserved human DPSCs (hDPSCs) ameliorate diabetic polyneuropathy, and the effects of hDPSC transplantation are related to VEGF and NGF secretion.
Masaki Hata, Maiko Omi, Yasuko Kobayashi, Nobuhisa Nakamura, Megumi Miyabe, Mizuho Ito, Tasuku Ohno, Yuka Imanishi, Tatsuhito Himeno, Hideki Kamiya, Jiro Nakamura, Hitoshi Miyachi, Shogo Ozawa, Ken Miyazawa, Akio Mitani, Toru Nagao, Shigemi Goto, Jun Takebe, Tatsuaki Matsubara, Keiko Naruse   +19 more
doaj   +1 more source

Update on the management of diabetic polyneuropathies

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2011
The prevalence of diabetic polyneuropathy (DPN) can approach 50% in subjects with longer-duration diabetes. The most common neuropathies are generalized symmetrical chronic sensorimotor polyneuropathy and autonomic neuropathy. It is important to recognize that 50% of subjects with DPN may have no symptoms and only careful clinical examination may ...
Shakher,Jayadave, Stevens,Martin J
openaire   +4 more sources

POEMS Syndrome: 2026 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Disease Overview POEMS syndrome is a life‐threatening syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley   +1 more source